Judge Favors Par In Novartis Alzheimer's Patch Patent Row
A Delaware federal judge on Friday found Novartis Pharmaceuticals Corp. hadn't shown Par Pharmaceutical Inc. infringed a patent for a patch that treats Alzheimer's disease, asking the generic-name drugmaker to file...To view the full article, register now.
Already a subscriber? Click here to view full article